Inflammatory processes always accompany with progression of cancer, which can contribute to tumorigenesis by supplying cytokines, such as vascular endothelial growth factor (VEGF), interleukin-18 and matrix metalloproteinases [34]–[36] to the tumor microenvironment that promotes angiogenesis, and thus promotes tumor growth and metastasis. This evidence concerns the gene IL18 and cancer.